BioSpace News Archive

LifeShield National Insurance Co. (“LifeShield”) announced that it has entered an agreement to acquire IAC Group, the parent company of Individual Assurance Company (“IAC”), a leading life, accident, and health insurer with a strong presence in the Medicare supplement market.

The National Institutes of Health (NIH) has awarded a seven-year, $23 million grant to researchers at Albert Einstein College of Medicine and Montefiore Health System to study HIV and the chronic illnesses that often accompany HIV infection, including cardiovascular and lung disease, diabetes, and cancer.

Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII) announced today that it filed suit against Vitalize Labs, LLC (doing business as Eboost) for infringing NAI’s CarnoSyn® beta-alanine trademarks.

This first World Food Safety Day is a recognition that when it comes to food safety, we all win or lose together. In a global food system and with the increase in international travel, if foodborne disease exists somewhere in the world, it can exist anywhere in the world

D2d is the largest study to examine vitamin D supplementation among people at high risk with sufficient vitamin D levels [07-June-2019] SAN FRANCISCO , June 7, 2019 /PRNewswire/ -- New research shows that daily oral vitamin D supplementation does not effectively reduce the risk of type 2 diabetes among vitamin D-sufficient adults at high risk for developing the diseas

The U.S. Food and Drug Administration permitted marketing of the first medical device to aid in the reduction of functional abdominal pain in patients 11-18 years of age with irritable bowel syndrome when combined with other therapies for IBS.

Amgen will present at the Goldman Sachs 40th Annual Global Healthcare Conference at 11:20 a.m. PT on Wednesday, June 12, 2019, in Rancho Palos Verdes, Calif.

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for the four proposals considered and voted upon by its stockholders at its Annual Meeting on June 6, 2019.

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced the latest gift of $131 million from its founding entrepreneur and philanthropist, Hansjörg Wyss.

Imara Inc. announced that the company will deliver an oral presentation on IMR-687 at the 24th Congress of the European Hematology Association being held from June 13 – 16, 2019, in Amsterdam.